CiMaas started in March 2015. The focus of CiMaas is the development of cellular immunotherapy for the treatment of cancer. The most advanced product is a dendritic cell (DC) vaccine. DC are able to activate the immune system and as such coordinate the activity of other immune cells that are able to attack the tumour cells. Currently CiMaas is busy to translate the research activities to clinical protocols and building it’s QM system in the new facility in Geleen. CiMaas expects to start a clinical trial with DC vaccines in later half of 2018. CiMaas further works on Natural Killer cell and develops the practical and clinical protocols as well as the QM documents for this.

Currently we are hiring a:

Cell Culture Technician (1.0 fte)

The challenge

You will have the opportunity to be part of a young, dynamic and strongly developed organization that is involved in combating cancer. As a member of a small and enthusiastic team of professionals, you make an important contribution to the challenging development of specific cell therapeutic agents in a GMP environment.

As a cell culture  technician, you report directly to the scientific director (CSO).

You work on the production of the DC vaccine and the NK cells, the preparation of SOPs AND the creation and validation of QA and QC protocols in accordance with GMP guidelines.

The ideal

  • HBO work and thinking level (eg HLO)
  • Relevant experience in cell culture, eg knowledge of bioreactors or scaling up of experiments
  • Several years of experience in a GMP environment is required
  • Good knowledge of the Dutch and English language in word and writing

The competencies

  • Enterpreneural
  • Taking initiative
  • A problem-solving attitude and a hands-on mentality
  • Being able to work independently and in a team
  • Good social skills
  • Quality-oriented and accurate
  • Flexible
  • Targeted and driven
  • Prepare to work in weekends / off-hours

The offer

We offer you an employment contract for a period of one year, with the possibility of extension and competitive market-oriented secondary benefits. The location is Geleen. An appointment of 0.8 FTE is negotiable.

Are you interested?

Send your CV and extended letter of motivation by e-mail before 19 February 2018 to: vacature at


For questions on content of the vacancy, please contact:

Dr Wilfred Germeraad, CSO via w.germeraad at



Acquisition as a result of this vacancy is not appreciated!